Delivery Order SPE2DB22D2005-SPE2DB24FJPW5

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,290.82 firm-fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets, with a completion date of May 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,004.59 firm fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has an ultimate completion date of March 14, 2025 and was awarded on March 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,989.77 firm fixed-price delivery order is for 4,564,689,910 units of ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,083.18 firm fixed-price delivery order is for the supply of 4 mg Ondansetron ODT (Orally Disintegrating Tablet) in 30-count bottles. The contract has an ultimate completion date of March 4, 2025 and was awarded on March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $50,011.20 firm fixed-price delivery order is for the supply of 4 mg ondansetron orodispersible tablets (ODT) in quantities of 30. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,978.24 firm fixed price delivery order contract is for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of July 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,241.75 Firm Fixed Price Delivery Order is for the supply of Ondansetron ODT 4 mg Tablets in quantities of 30s. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,454.34 firm-fixed-price delivery order is for the supply of 4,560,149,920 ondansetron orally disintegrating tablets, 4 mg, in 30-count packages. The award has an ultimate completion date of March 7, 2023 and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,656.98 firm fixed-price delivery order is for Ondansetron ODT 4 mg tablets, with a completion date of February 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is a delivery order worth $18,360.44 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is for the supply of Ondansetron ODT 4 mg tablets. The contract has a completion date of March 26, 2025 and is a firm fixed price contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJPW5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 10, 2024. The $38,333.26 firm fixed-price delivery order is for the supply of 30-count packs of 4 mg ondansetron orally disintegrating tablets. The award is not designated under any set-aside program.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracts enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 9:51 AM